| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 6, Issue 9 1103-1110, Copyright © 1995 by American Association of Cancer Research
ARTICLES |
P Horvath, A Suganuma, M Inaba, YB Pan and KC Gupta
Department of Immunology/Microbiology, Rush Medical College, Chicago, Illinois 60612, USA.
Expression of the platelet derived growth factor (PDGF) B-chain, the product of the c-sis proto-oncogene, is regulated both at the transcriptional and translational level. Previous studies have shown that the long 5' untranslated region (UTR) of the c-sis mRNA strongly inhibits synthesis of the PDGF-B chain. However, the assignments of down-regulatory regions within the 5' UTR were ambiguous. Expression of several site-directed point and deletion mutants of the 5' UTR of the c-sis mRNA in COS1 cells revealed that the UTR inhibited PDGF-B chain synthesis in a more complex manner than indicated by the previous studies. Abrogation of the three upstream short open reading frames by mutating each of the AUGs did not have any effect on the synthesis of the PDGF-B chain. Expression of deletion mutants revealed two partially overlapping regions, nucleotides 1-651 and 475-1022, each of which independently inhibited c-sis mRNA translation as effectively as the entire 5' UTR. Each of these regions contains a potentially strong stem-loop structure and a GC-rich element. These elements of the alternate down-regulatory regions could interact within the same region and/or with the elements of the other regulatory region to block c-sis mRNA translation. We show, in contrast to the previous reports, that the inhibition of c-sis mRNA translation cannot be attributed exclusively to any particular predicted secondary structure or a GC-rich element within the 5' UTR.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
A. H. Shih, C. Dai, X. Hu, M. K. Rosenblum, J. A. Koutcher, and E. C. Holland Dose-Dependent Effects of Platelet-Derived Growth Factor-B on Glial Tumorigenesis Cancer Res., July 15, 2004; 64(14): 4783 - 4789. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Gopfert, M. Kullmann, and L. Hengst Cell cycle-dependent translation of p27 involves a responsive element in its 5'-UTR that overlaps with a uORF Hum. Mol. Genet., July 15, 2003; 12(14): 1767 - 1779. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Han and J.-T. Zhang Regulation of Gene Expression by Internal Ribosome Entry Sites or Cryptic Promoters: the eIF4G Story Mol. Cell. Biol., November 1, 2002; 22(21): 7372 - 7384. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Kowalski and D. L. Mager A Human Endogenous Retrovirus Suppresses Translation of an Associated Fusion Transcript, PLA2L J. Virol., July 1, 1998; 72(7): 6164 - 6168. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bernstein, O. Sella, S.-Y. Le, and O. Elroy-Stein PDGF2/c-sis mRNA Leader Contains a Differentiation-linked Internal Ribosomal Entry Site (D-IRES) J. Biol. Chem., April 4, 1997; 272(14): 9356 - 9362. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |